 |
PDBsum entry 3f6y
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Conformational closure of the catalytic site of human cd38 induced by calcium
|
|
Structure:
|
 |
Adp-ribosyl cyclase 1. Chain: a. Fragment: enzymatic domain, extracellular domain. Synonym: cyclic adp-ribose hydrolase 1, cadpr hydrolase 1, t10, cd38 antigen. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: cd38. Expressed in: pichia pastoris. Expression_system_taxid: 4922.
|
|
Resolution:
|
 |
|
1.45Å
|
R-factor:
|
0.148
|
R-free:
|
0.184
|
|
|
Authors:
|
 |
Q.Liu,R.Graeff,I.A.Kriksunov,C.M.C.Lam,H.C.Lee,Q.Hao
|
|
Key ref:
|
 |
Q.Liu
et al.
(2008).
Conformational Closure of the Catalytic Site of Human CD38 Induced by Calcium.
Biochemistry,
47,
13966-13973.
PubMed id:
|
 |
|
Date:
|
 |
|
07-Nov-08
|
Release date:
|
18-Nov-08
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P28907
(CD38_HUMAN) -
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
300 a.a.
235 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 6 residue positions (black
crosses)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 1:
|
 |
E.C.2.4.99.20
- 2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
nicotinate + NADP+ = nicotinate-adenine dinucleotide phosphate + nicotinamide
|
 |
 |
 |
 |
 |
nicotinate
|
+
|
NADP(+)
|
=
|
nicotinate-adenine dinucleotide phosphate
|
+
|
nicotinamide
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 2:
|
 |
E.C.3.2.2.-
- ?????
|
|
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
E.C.3.2.2.6
- ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
NAD+ + H2O = ADP-D-ribose + nicotinamide + H+
|
 |
 |
 |
 |
 |
NAD(+)
|
+
|
H2O
|
=
|
ADP-D-ribose
|
+
|
nicotinamide
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Biochemistry
47:13966-13973
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Conformational Closure of the Catalytic Site of Human CD38 Induced by Calcium.
|
|
Q.Liu,
R.Graeff,
I.A.Kriksunov,
C.M.Lam,
H.C.Lee,
Q.Hao.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
First identified on the surface of lymphoids as a type II transmembrane protein,
CD38 has now been established to have dual functions not only as a receptor but
also as a multifunctional enzyme,catalyzing the synthesis of and hydrolysis of a
general calcium messenger molecule, cyclic ADP-ribose(cADPR). The receptorial
functions of CD38 include the induction of cell adhesion,
differentiation,apoptosis, and cytokine production upon antibody ligation. Here
we determined the crystal structure of calcium-loaded human CD38 at 1.45 A
resolution which reveals that CD38 undergoes dramatic structural changes to an
inhibited conformation in the presence of calcium. The structural changes are
highly localized and occur in only two regions. The first region is part of the
active site and consists of residues 121-141.In the presence of calcium, W125
moves 5 A into the active site and forms hydrophobic interactions with W189. The
movement closes the active site pocket and reduces entry of substrates,
resulting in inhibition of the enzymatic activity. The structural role of
calcium in inducing these conformational changes is readily visualized in the
crystal structure. The other region that undergoes calcium-induced changes is at
the receptor region, where a highly ordered helix is unraveled to a random coil.
The results suggest a novel conformational coupling mechanism, whereby protein
interaction targeted at the receptor region can effectively regulate the
enzymatic activity of CD38.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |